[go: up one dir, main page]

CA3265713A1 - Procedure for production of opioid-antagonist-releasing compounds and their use as a medicine - Google Patents

Procedure for production of opioid-antagonist-releasing compounds and their use as a medicine

Info

Publication number
CA3265713A1
CA3265713A1 CA3265713A CA3265713A CA3265713A1 CA 3265713 A1 CA3265713 A1 CA 3265713A1 CA 3265713 A CA3265713 A CA 3265713A CA 3265713 A CA3265713 A CA 3265713A CA 3265713 A1 CA3265713 A1 CA 3265713A1
Authority
CA
Canada
Prior art keywords
opioid
antagonist
medicine
procedure
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3265713A
Other languages
French (fr)
Inventor
Thilo Fischer
Fong-Chin Huang
James Ferri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosynth GmbH
Virginia Commonwealth University
Original Assignee
Biosynth GmbH
Virginia Commonwealth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosynth GmbH, Virginia Commonwealth University filed Critical Biosynth GmbH
Publication of CA3265713A1 publication Critical patent/CA3265713A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/01Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/01Hexosyltransferases (2.4.1)
    • C12Y204/01017Glucuronosyltransferase (2.4.1.17)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA3265713A 2022-08-25 2023-08-25 Procedure for production of opioid-antagonist-releasing compounds and their use as a medicine Pending CA3265713A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263400998P 2022-08-25 2022-08-25
PCT/EP2023/073401 WO2024042226A2 (en) 2022-08-25 2023-08-25 Procedure for production of opioid-antagonist-releasing compounds and their use as a medicine

Publications (1)

Publication Number Publication Date
CA3265713A1 true CA3265713A1 (en) 2024-02-29

Family

ID=87886720

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3265713A Pending CA3265713A1 (en) 2022-08-25 2023-08-25 Procedure for production of opioid-antagonist-releasing compounds and their use as a medicine

Country Status (3)

Country Link
EP (1) EP4577667A2 (en)
CA (1) CA3265713A1 (en)
WO (1) WO2024042226A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716452B1 (en) * 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6740641B2 (en) * 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain
JP5266492B2 (en) * 2004-05-28 2013-08-21 ヒューマン バイオモレキュラル リサーチ インスティテュート Metabolic stable analgesics, pain pharmacotherapy and synthesis of other substances
CA2682125C (en) * 2007-03-29 2015-06-16 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof

Also Published As

Publication number Publication date
EP4577667A2 (en) 2025-07-02
WO2024042226A3 (en) 2024-04-18
WO2024042226A2 (en) 2024-02-29

Similar Documents

Publication Publication Date Title
PT4255442T (en) Jak inhibitor with a vitamin d analog for treatment of skin diseases
ZA202105848B (en) Applicator for oral administration of a swallowable object to a patient
EP4228629A4 (en) Process for preparation of tafamidis and salts thereof
CA3265713A1 (en) Procedure for production of opioid-antagonist-releasing compounds and their use as a medicine
CA3263211A1 (en) Therapeutic uses of urolithin derivatives
IL299031A (en) Contained production of pharmaceutically pure crystals
HUP2100414A1 (en) Process for preparation of bioadsorbent material
IL316558A (en) New medical use of tafoxiparin
CA218888S (en) Part of medicine injector
IL287091A (en) Process for making drug crystals of desired size distribution and morphology
GB202306449D0 (en) Production of carbon compounds
CA3252744A1 (en) Novel process and intermediate for the preparation of apalutamide
IL309484A (en) Process for the preparation of a cyp11a1 inhibitor and intermediates thereof
ZA202105144B (en) Oral pharmaceutical composition with a plant alkaloid for treatment of dependencies
GB202020555D0 (en) Process for the preparation of a pharmaceutical solution
CA218886S (en) Part of medicine injector
CA218884S (en) Part of medicine injector
CA218885S (en) Part of medicine injector
CA218887S (en) Part of medicine injector
CA219048S (en) Part of medicine injector
CA219049S (en) Part of medicine injector
CA219051S (en) Part of medicine injector
AU2022900189A0 (en) Anthelmintic compounds and methods of manufacture and therapeutic use
HUP2300416A1 (en) Process for preparation of abrocitinib
GB202219474D0 (en) Novel process for the manufacture of therapeutic agents